A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

The emergence of GLP-1 medications in recent years has presented a promising option for many people who are struggling with weight management. With celebrity promotions and advertisements dominating ...

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

A study claimed that people who eat high-fat, low-carb diets weren’t seeing their arteries fill up with plaque, despite ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

The TV and radio presenter and podcast host died while on holiday with his wife Dr Clare Bailey Mosley on the Greek island of Symi last year.

The full data from the 751-subject SURMOUNT-5 trial was published in the New England Journal of Medicine over ... In the results, dual GLP-1/GIP agonist Zepbound (tirzepatide) outperformed GLP ...